These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 17349582)
1. In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. Mutlu AD; Cavallin LE; Vincent L; Chiozzini C; Eroles P; Duran EM; Asgari Z; Hooper AT; La Perle KM; Hilsher C; Gao SJ; Dittmer DP; Rafii S; Mesri EA Cancer Cell; 2007 Mar; 11(3):245-58. PubMed ID: 17349582 [TBL] [Abstract][Full Text] [Related]
2. A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis. Ma Q; Cavallin LE; Leung HJ; Chiozzini C; Goldschmidt-Clermont PJ; Mesri EA Antioxid Redox Signal; 2013 Jan; 18(1):80-90. PubMed ID: 22746102 [TBL] [Abstract][Full Text] [Related]
3. KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma. Ma T; Patel H; Babapoor-Farrokhran S; Franklin R; Semenza GL; Sodhi A; Montaner S Angiogenesis; 2015 Oct; 18(4):477-88. PubMed ID: 26092770 [TBL] [Abstract][Full Text] [Related]
4. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Bais C; Santomasso B; Coso O; Arvanitakis L; Raaka EG; Gutkind JS; Asch AS; Cesarman E; Gershengorn MC; Mesri EA Nature; 1998 Jan; 391(6662):86-9. PubMed ID: 9422510 [TBL] [Abstract][Full Text] [Related]
5. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma. Montaner S; Sodhi A; Ramsdell AK; Martin D; Hu J; Sawai ET; Gutkind JS Cancer Res; 2006 Jan; 66(1):168-74. PubMed ID: 16397229 [TBL] [Abstract][Full Text] [Related]
6. High-throughput sequencing analysis of a "hit and run" cell and animal model of KSHV tumorigenesis. Naipauer J; Salyakina D; Journo G; Rosario S; Williams S; Abba M; Shamay M; Mesri EA PLoS Pathog; 2020 Jun; 16(6):e1008589. PubMed ID: 32603362 [TBL] [Abstract][Full Text] [Related]
7. CD147 and downstream ADAMTSs promote the tumorigenicity of Kaposi's sarcoma-associated herpesvirus infected endothelial cells. Dai L; Trillo-Tinoco J; Chen Y; Bonstaff K; Del Valle L; Parsons C; Ochoa AC; Zabaleta J; Toole BP; Qin Z Oncotarget; 2016 Jan; 7(4):3806-18. PubMed ID: 26675551 [TBL] [Abstract][Full Text] [Related]
8. Role of heme oxygenase-1 in the pathogenesis and tumorigenicity of Kaposi's sarcoma-associated herpesvirus. Dai L; Qiao J; Nguyen D; Struckhoff AP; Doyle L; Bonstaff K; Del Valle L; Parsons C; Toole BP; Renne R; Qin Z Oncotarget; 2016 Mar; 7(9):10459-71. PubMed ID: 26859574 [TBL] [Abstract][Full Text] [Related]
9. Manipulation of endothelial cells by KSHV: implications for angiogenesis and aberrant vascular differentiation. Ojala PM; Schulz TF Semin Cancer Biol; 2014 Jun; 26():69-77. PubMed ID: 24486643 [TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen prolongs the life span of primary human umbilical vein endothelial cells. Watanabe T; Sugaya M; Atkins AM; Aquilino EA; Yang A; Borris DL; Brady J; Blauvelt A J Virol; 2003 Jun; 77(11):6188-96. PubMed ID: 12743275 [TBL] [Abstract][Full Text] [Related]
11. Angiopoietin-like 4: a novel molecular hallmark in oral Kaposi's sarcoma. Hu J; Jham BC; Ma T; Friedman ER; Ferreira L; Wright JM; Accurso B; Allen CM; Basile JR; Montaner S Oral Oncol; 2011 May; 47(5):371-5. PubMed ID: 21421336 [TBL] [Abstract][Full Text] [Related]
12. Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcoma. Jham BC; Ma T; Hu J; Chaisuparat R; Friedman ER; Pandolfi PP; Schneider A; Sodhi A; Montaner S PLoS One; 2011 Apr; 6(4):e19103. PubMed ID: 21559457 [TBL] [Abstract][Full Text] [Related]
13. Productively infected murine Kaposi's sarcoma-like tumors define new animal models for studying and targeting KSHV oncogenesis and replication. Ashlock BM; Ma Q; Issac B; Mesri EA PLoS One; 2014; 9(1):e87324. PubMed ID: 24489895 [TBL] [Abstract][Full Text] [Related]
14. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Flore O; Rafii S; Ely S; O'Leary JJ; Hyjek EM; Cesarman E Nature; 1998 Aug; 394(6693):588-92. PubMed ID: 9707121 [TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells. Vart RJ; Nikitenko LL; Lagos D; Trotter MW; Cannon M; Bourboulia D; Gratrix F; Takeuchi Y; Boshoff C Cancer Res; 2007 May; 67(9):4042-51. PubMed ID: 17483315 [TBL] [Abstract][Full Text] [Related]
18. Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway. Zhu X; Guo Y; Yao S; Yan Q; Xue M; Hao T; Zhou F; Zhu J; Qin D; Lu C Oncogene; 2014 Apr; 33(15):1986-96. PubMed ID: 23604117 [TBL] [Abstract][Full Text] [Related]
19. An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia. Martin D; Galisteo R; Ji Y; Montaner S; Gutkind JS Oncogene; 2008 Mar; 27(13):1844-52. PubMed ID: 17934524 [TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor II receptor-mediated intracellular retention of cathepsin B is essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus. Rose PP; Bogyo M; Moses AV; Früh K J Virol; 2007 Aug; 81(15):8050-62. PubMed ID: 17507477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]